Celebrating 25 Years of TKIs

In 1999, the first tyrosine kinase inhibitor (TKI) transformed the treatment of chronic myeloid leukemia - and changed the course of cancer care worldwide.

This year, we mark 25 years since that breakthrough. It’s more than a scientific milestone - it’s a story of lives extended and a global community working to ensure access to treatment for all.

To honor this anniversary, the iCMLf is sharing reflections, resources, and real-world impact from across our network:

Read the Campaign Announcement

Learn how the iCMLf is recognising this global milestone and how you can get involved.

Explore the Timeline

Walk through the milestones of 25 years of progress in the development of TKIs.

Read the Dr. Brian Druker Interview

Hear directly from the man who helped pioneer TKIs, reflecting on what’s changed - and what comes next.